← Open Payments lookup

ANGELA MANGUM: Open Payments

NPI 1568108025 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$946 in 47 payments from 8 companies in 2025. Trend: 2023 $656 · 2024 $1,094 · 2025 $946

Food & beverage: $946
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$289
ABBVIE INC.18$278
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$210
Indivior Inc.3$58
Axsome Therapeutics, Inc.2$47
Takeda Pharmaceuticals U.S.A., Inc.2$27
Vanda Pharmaceuticals Inc.1$18
Teva Pharmaceuticals USA, Inc.1$18

Products named: VRAYLAR, CAPLYTA, REXULTI, ABILIFY MAINTENA, SUBLOCADE, Auvelity, TRINTELLIX, FANAPT.

Industry payments across NV — which companies pay providers there.